Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplantation of Human iPS Cell-derived Cerebral Cortical Neurons Promotes Fine Motor Recovery in a Female Mouse Model of Ischemic Stroke.

Stem cell reviews and reports·2025
Same author

Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell.

eLife·2024
Same author

Vascular therapy for Duchenne muscular dystrophy (DMD).

Faculty reviews·2023
Same author

The Notch signaling pathway in skeletal muscle health and disease.

Muscle & nerve·2022
Same author

Publisher Correction: The endothelial Dll4-muscular Notch2 axis regulates skeletal muscle mass.

Nature metabolism·2022
Same author

The endothelial Dll4-muscular Notch2 axis regulates skeletal muscle mass.

Nature metabolism·2022

Related Experiment Video

Updated: Mar 2, 2026

In Vitro Generation of Somite Derivatives from Human Induced Pluripotent Stem Cells
06:21

In Vitro Generation of Somite Derivatives from Human Induced Pluripotent Stem Cells

Published on: April 25, 2019

10.0K

Skeletal Muscle Cell Induction from Pluripotent Stem Cells.

Yusaku Kodaka1,2,3, Gemachu Rabu1,2,3, Atsushi Asakura1,2,3

  • 1Stem Cell Institute, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Stem Cells International
|May 23, 2017
PubMed
Summary

Embryonic stem cells and induced pluripotent stem cells can become skeletal muscle cells, offering hope for muscular dystrophy. Patient-derived cells are ideal for regenerative medicine to avoid immune rejection.

More Related Videos

Generation of Myospheres From hESCs by Epigenetic Reprogramming
09:32

Generation of Myospheres From hESCs by Epigenetic Reprogramming

Published on: June 21, 2014

8.3K
Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells
09:11

Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells

Published on: January 28, 2015

11.7K

Related Experiment Videos

Last Updated: Mar 2, 2026

In Vitro Generation of Somite Derivatives from Human Induced Pluripotent Stem Cells
06:21

In Vitro Generation of Somite Derivatives from Human Induced Pluripotent Stem Cells

Published on: April 25, 2019

10.0K
Generation of Myospheres From hESCs by Epigenetic Reprogramming
09:32

Generation of Myospheres From hESCs by Epigenetic Reprogramming

Published on: June 21, 2014

8.3K
Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells
09:11

Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells

Published on: January 28, 2015

11.7K

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Skeletal Muscle Development

Background:

  • Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) can differentiate into various cell types, including skeletal muscle.
  • Skeletal muscle diseases like Duchenne muscular dystrophy (DMD) present significant therapeutic challenges.
  • Patient-derived iPSCs offer a promising source for autologous cell therapies, minimizing immune rejection concerns.

Purpose of the Study:

  • To review current methods for differentiating ESCs and iPSCs into skeletal muscle cells.
  • To highlight recent advancements in skeletal muscle cell induction techniques.
  • To discuss the potential of these methods for treating skeletal muscle diseases.

Main Methods:

  • Overexpression of key myogenic transcription factors (e.g., MyoD, Pax3).
  • Small molecule-induced differentiation pathways to generate mesodermal and myogenic progenitor cells.
  • Leveraging epigenetic memory in iPSCs derived from muscle cells.

Main Results:

  • Successful differentiation protocols for generating skeletal muscle cells from pluripotent stem cells have been developed.
  • Mimicking embryonic mesodermal and subsequent myogenic induction is crucial for efficient differentiation.
  • Various strategies, including genetic manipulation and small molecules, show promise.

Conclusions:

  • Converting ESCs/iPSCs into skeletal muscle cells is a viable strategy for regenerative medicine.
  • Patient-specific iPSCs are particularly valuable for transplantation, avoiding immune rejection.
  • Continued research into optimizing differentiation protocols is essential for clinical applications in treating muscle diseases.